Projects per year
Search results
-
Active
Periostin in bladder cancer: EMT, metastatic potential and potential crosstalk with the TAM receptor signaling.
Riethmacher, D. (PI), Riethmacher, E. (Co-PI), Tulchinsky, E. (Other Faculty/Researcher), Gushchin, D. (Other Faculty/Researcher), Bryan, R. T. (Other Faculty/Researcher) & Ward, D. (Other Faculty/Researcher)
1/1/24 → 12/31/26
Project: FDCRGP
-
Genetically engineered Microbiome as a new treatment option for Inflammatory bowel disease
Riethmacher, E. (PI)
1/1/24 → 12/31/26
Project: Government
-
Finished
Expanding the therapeutic landscape of CCR5 blockade and CCL5 engineering
Riethmacher, E. (PI) & Bulanin, D. (Other Faculty/Researcher)
1/1/21 → 12/31/23
Project: FDCRGP
-
Analyzing the roles of Periostin in bladder cancer
Riethmacher, D. (PI), Riethmacher, E. (Co-PI) & Kriajevskaia, M. (Other Faculty/Researcher)
1/1/21 → 12/31/23
Project: FDCRGP
-
Clinicopathologic Features and Immunohistochemical Characteristics of DNA Mismatch Repair Deficient Colorectal Cancer Among Kazakhstani Patients
Tanko, M. N. (PI), Midlenko, A. (Co-PI), Ashimkhanova, A. (Co-PI), Riethmacher, D. (Co-PI) & Riethmacher, E. (Co-PI)
9/1/19 → 9/30/20
Project: Social Policy
-
Periostin in development and progression of colorectal cancer
Riethmacher, E. (PI), Riethmacher, D. (Co-PI) & Ashimkhanova, A. (Co-PI)
1/31/19 → 6/30/22
Project: FDCRGP
-
Periostin in inflammatory bowel disease (IBD) development and synergistic effects mediated via CCL5 and MMP9.
Riethmacher, D. (PI), Riethmacher, E. (Other Faculty/Researcher), Vangelista, L. (Other Faculty/Researcher), Ashimkhanova, A. (Other Faculty/Researcher), Adrisova, K. (Co-PI), Kuatbai, G. (Other participant), Kim , A. K. (Other participant) & Ainur Abdrakhmanova, A. (Other participant)
1/1/18 → 6/30/21
Project: FDCRGP